4.1 Target species
Dogs.
4.2 Indications for use, specifying the target species
In dogs: Treatment of mixed infections by nematodes and cestodes of the following
species
Nematodes:
Ascarids: Toxocara canis, Toxascaris leonina (adult and late immature forms).
Hookworms: Uncinaria stenocephala, Ancylostoma caninum (adults).
Whipworms: Trichuris vulpis (adults).
Cestodes:
Tapeworms: Echinococcus species, (E. granulosus, E. multilocularis), Taenia
species,
(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum (adult and immature
forms). Revised: October 2019
AN: 00846/2019
Page 2 of 6
4.3 Contraindications
Do not use simultaneously with piperazine compounds.
Do not use in animals with a known sensitivity to the active ingredients or to any of
the excipients.
4.4 Special warnings for each target species
Fleas serve as intermediate hosts for one common type of tapeworm – Dipylidium
caninum. Tapeworm infestation is certain to reoccur unless control of intermediate
hosts such as fleas, mice, etc. is undertaken.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
Parasite resistance to any particular class of anthelmintic may develop following
frequent, repeated use of an anthelmintic of that class.
4.5 Special precautions for use
Special precautions for use in animals
None.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
In case of accidental ingestion, seek medical advice and show the package leaflet to
the physician.
In the interests of good hygiene, persons administering the tablets directly to the dog,
or by adding them to the dog’s food, should wash their hands afterwards.
Echinococcosis represents a hazard for humans. As echinococcosis is a notifiable
disease to the World Organisation for Animal Health (OIE), specific guidelines on the
treatment and follow-up, and on the safeguard of persons, need to be obtained from
the relevant competent authority.
4.6 Adverse reactions (frequency and seriousness)
In very rare cases, gastrointestinal disorders (diarrhoea, emesis) have been
observed.
4.7 Use during pregnancy, lactation or lay
Teratogenic effects attributed to high doses of febantel have been reported in sheep
and rats. No studies have been performed in dogs during early pregnancy. Use of the
product during pregnancy should be in accordance with a benefit risk assessment by
the responsible veterinarian. It is recommended that the product is not used in dogs
during the first 4 weeks of pregnancy. Do not exceed the stated dose when treating
pregnant bitches.Revised: October 2019
AN: 00846/2019
Page 3 of 6
4.8 Interaction with other medicinal products and other forms of interaction
Do not use simultaneously with piperazine compounds as the anthelmintic effects of
pyrantel and piperazine may be antagonized.
Concurrent use with other cholinergic compounds can lead to toxicity.